Clinical trials recruiting for Clinical Stage IV Cutaneous Melanoma AJCC v8
13
Recruiting trials
41
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 5 |
| Ohio | 4 |
| California | 3 |
| Georgia | 3 |
| Illinois | 3 |
| Minnesota | 3 |
| Missouri | 3 |
| New York | 3 |
| Pennsylvania | 3 |
| Texas | 3 |
| Utah | 3 |
| Arkansas | 2 |
Top cities
Chicago, Illinois 3Columbus, Ohio 3Houston, Texas 3Jacksonville, Florida 3Los Angeles, California 3Salt Lake City, Utah 3St Louis, Missouri 3Ames, Iowa 2Anaconda, Montana 2Ann Arbor, Michigan 2
Self-screener
Recruiting trials
- A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
- Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
- Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
- Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
- Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial
Related conditions
Trials recruiting for Clinical Stage IV Cutaneous Melanoma AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.
Melanoma 487Metastatic Melanoma 40Clinical Stage III Cutaneous Melanoma AJCC v8 7Pathologic Stage IV Cutaneous Melanoma AJCC v8 6Stage IV Lung Cancer AJCC v8 45Stage III Lung Cancer AJCC v8 22Metastatic Cutaneous Melanoma 6Lung cancer 2180Unresectable Melanoma 11Unresectable Cutaneous Melanoma 3
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Clinical Stage IV Cutaneous Melanoma AJCC v8 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.